Advancement of Structure-Activity Relationship of Multidrug Resistance-Associated Protein 2 Interactions

被引:10
作者
Xing, Li [1 ]
Hu, Yiding [1 ]
Lai, Yurong [1 ]
机构
[1] Pfizer Global Res & Dev, St Louis Labs, Chesterfield, MO 63017 USA
关键词
ABC transporters; ADME/Tox; MRP2/ABCC2; structure-activity relationship; ORGANIC ANION TRANSPORTER; CONJUGATE EXPORT PUMPS; P-GLYCOPROTEIN ASSAYS; SUBSTRATE-SPECIFICITY; DRUG-RESISTANCE; METHOTREXATE ANALOGS; EFFLUX TRANSPORTERS; MEDIATED TRANSPORT; MRP FAMILY; RAT;
D O I
10.1208/s12248-009-9117-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multidrug resistance-associated protein 2 (MRP2/ABCC2) is mainly expressed in the apical phase of barrier membranes. It functions as a critical efflux pump in the biliary excretion of endogenous substances, such as conjugated bilirubin and bile salts, as well as many structurally diverse xenobiotics and their metabolites. Due to its important role in defining ADME/Tox properties, efforts have emerged to build the structure-activity relationship (SAR) for MRP2/ABCC2 at early stages of drug discovery process. MRP2/ABCC2 is a member of the integral membrane protein family whose high-resolution crystal structure has not been described. To overcome the obstacle of lacking detailed structural depiction, various molecular modeling approaches have been applied to derive the structural requirements for binding interactions with MRP2/ABCC2 protein, including two-dimensional (2D) and three-dimensional (3D) quantitative SAR (QSAR) analysis, pharmacophore models, and homology modeling of the transporter. Here we summarize recent progresses in understanding the SAR of MRP2/ABCC2 recognition of substrates and/or inhibitors, and describe some of the useful in vitro tools for characterizing the interactions with the transporter.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 92 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[3]   Stoichiometry of organic anion/dicarboxylate exchange in membrane vesicles from rat renal cortex and hOAT1-expressing cells [J].
Aslamkhan, A ;
Han, YH ;
Walden, R ;
Sweet, DH ;
Pritchard, JB .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (04) :F775-F783
[4]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[5]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[6]   Anticancer multidrug resistance mediated by MRP1: Recent advances in the discovery of reversal agents [J].
Boumendjel, A ;
Baubichon-Cortay, H ;
Trompier, D ;
Perrotton, T ;
Di Pietro, A .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (04) :453-472
[7]  
Buchler M, 1996, J BIOL CHEM, V271, P15091
[8]   Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286
[9]   Structure of MsbA from E. coli:: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters (Retraction of vol 293, pg 1793, 2001) [J].
Chang, Geoffrey ;
Roth, Christopher B. ;
Reyes, Christopher L. ;
Pornillos, Owen ;
Chen, Yen-Ju ;
Chen, Andy P. .
SCIENCE, 2006, 314 (5807) :1875-1875
[10]   Reversal of P-glycoprotein-mediated MDR by 5,7,3′,4′,5′-pentamethoxyflavone and SAR [J].
Choi, CH ;
Kim, JH ;
Kim, SH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) :672-679